Latest drug discovery Stories
Lawrence Livermore National Laboratory researchers recently published an article in PLOS ONE detailing the use of supercomputers to link proteins to drug side effects.
WHITE PLAINS, N.Y., Oct.
ENGLEWOOD, Colo., Oct. 20, 2014 /PRNewswire/ -- Luoxis Diagnostics, Inc., a subsidiary of Ampio Pharmaceuticals, Inc.
DIA in cooperation with SureClinical will host a complimentary webinar "How New Electronic Trial Master File (eTMF) Data Standards Can Enhance Clinical Trial Efficiency and Quality"
LONDON, Oct. 15. 30, 2014 /PRNewswire/ -- REPORT HIGHLIGHTS The global market for ADC drugs reached $179 million in 2012 and $396 million in 2013.
Selexis has promoted director of European business development, Marco Bocci, PhD, PharmD, to Vice President, European Licensing and Business Development for Europe. Geneva,
LONDON, Oct. 14, 2014 /PRNewswire/ -- REPORT HIGHLIGHTSThe global market for signal transduction therapies/inhibitors (JAK and PI3K) reached $173.5 million in 2012.
The market is mainly driven by the increasing research funding for metabolomics from governments and private investors, growing demand for personalized medicine in the U.S.
- A trick or prank.